68884-06-0Relevant articles and documents
INHIBITORS OF FATTY ACID BINDING PROTEIN
-
Page/Page column 74, (2012/05/21)
The present invention relates to novel heterocyclic compounds as Fatty Acid Binding Protein (“FABP”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose.
Alkylamination of Pteridines by Primary Alkylamines - Potassium Permanganate
Sladowska, H.,van Veldhuizen, A.,van der Plas, H. C.
, p. 843 - 847 (2007/10/02)
Reaction of 7-phenyl, 7-p-methoxyphenyl, 7-t-butyl- and 6,7-diphenylpteridine with ethylamine and t-butylamine in the presence of potassium permanganate leads to the introduction of the ethylamino or t-butylamino group at C-4 in the above-mentioned pterid
